

Publisher: Karnac Books
ISSN: 2052-1782
Source: Neuro-Disability and Psychotherapy, Vol.2, Iss.1-2, 2014-01, pp. : 19-40
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Treatment of active secondary progressive multiple sclerosis with treosulfan
By Wiendl H. Kieseier B. Weissert R. Mylius H. Pichlmeier U. Hartung H.-P. Melms A. Kuker W. Weller M.
Journal of Neurology, Vol. 254, Iss. 7, 2007-07 ,pp. :



